Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents

Brain Research

Volumn 1215, Issue , 2008, Pages 218-224

  Hyong, Amy ^a   Jadhav, Vikram ^a   Lee, Steve ^a   Tong, Wenni ^a   Rowe, Jamaine ^a   Zhang, John H ^a   Tang, Jiping ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Brain edema; Inflammation; Myeloperoxidase; Rosiglitazone; Surgical brain injury

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURY; BRAIN TISSUE; CONTROLLED STUDY; DRUG MEGADOSE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; STAINING;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; INFLAMMATION; INTRAOPERATIVE COMPLICATIONS; MALE; NEUROPROTECTIVE AGENTS; NEUROSURGICAL PROCEDURES; PEROXIDASE; POSTOPERATIVE COMPLICATIONS; PPAR GAMMA; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES; TREATMENT OUTCOME;

ANIMALIA; RATTUS; RODENTIA;

EID: 44649087641     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.04.025     Document Type: Article

References (29)

1. Andrews R.J., and Muto R.P. Retraction brain ischaemia: cerebral blood flow, evoked potentials, hypotension and hyperventilation in a new animal model. Neurol. Res. 14 (1992) 12-18
2. Allahtavakoli M., Shabanzadeh A.P., Sadr S.S., Parviz M., and Djahanguiri B. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke. Clin. Exp. Pharmacol. Physiol. 33 11 (2006) 1052-1058
3. Bye N., Habgood M.D., Callaway J.K., Malakooti N., Potter A., Kossmann T., and Morganti-Kossmann M.C. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp. Neurol. 204 1 (2007) 220-233
4. Byrnes K.R., and Faden A.I. Role of cell cycle proteins in CNS injury. Neurochem. Res. 32 10 (2007) 1799-1807
5. Chen S.D., Wu H.Y., Yang D.I., Lee S.Y., Shaw F.Z., Lin T.K., Liou C.W., and Chuang Y.C. Effects of rosiglitazone on global ischemia-induced hippocampal injury and expression of mitochondrial uncoupling protein 2. Biochem. Biophys. Res. Commun. 351 1 (2006) 198-203
6. Deletis V., and Sala F. The role of intraoperative neurophysiology in the protection or documentation of surgically induced injury to the spinal cord. Ann. N.Y. Acad. Sci. 939 (2001) 137-144
7. Esiri M.M. The interplay between inflammation and neurodegeneration in CNS disease. J. Neuroimmunol. 184 1-2 (2007) 4-16 2007
8. Fasano V.A., and Penna G. Postoperative complications in neurosurgery. Minerva Anestesiol. 58 (1992) 15-21
9. Jadhav V., Solaroglu I., Obenaus A., and Zhang J.H. Neuroprotection against surgically induced brain injury. Surg. Neurol. 67 1 (2007) 15-20
10. Jadhav V., Matchett G., Hsu F.P., and Zhang J.H. Inhibition of Src tyrosine kinase and effect on outcomes in a new in vivo model of surgically induced brain injury. J. Neurosurg. 106 4 (2007) 680-686
11. Kelley B.J., Lifshitz J., and Povlishock J.T. Neuroinflammatory responses after experimental diffuse traumatic brain injury. J. Neuropathol. Exp. Neurol. 66 11 (2007) 989-1001
12. Lo W., Bravo T., Jadhav V., Titova E., Zhang J.H., and Tang J. NADPH oxidase inhibition improves neurological outcomes in surgically-induced brain injury. Neurosci. Lett. 414 3 (2007) 228-232
13. Luo Y., Yin W., Signore A.P., Zhang F., Hong Z., Wang S., Graham S.H., and Chen J. Neuroprotection against focal ischemic brain injury by the peroxisome proliferators-activated receptor-γ agonist rosiglitazone. J. Neurochem. 97 (2006) 435-448
14. Manninen P.H., Raman S.K., Boyle K., and El Beheiry H. Early postoperative complications following neurosurgical procedures. Can. J. Anaesth. 46 (1999) 7-14
15. Matchett G., Hahn J., Obenaus A., and Zhang J.H. Surgically induced brain injury in rats: the effect of erythropoietin. J. Neurosci. Methods 158 (2006) 234-241
16. Park S.W., Yi J.H., Miranpuri G., Satriotomo I., Bowen K., Resnick D.K., and Vemuganti R. Thiazolidinedione class of peroxisome proliferator-activated receptor-γ agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J. Pharmacol. Exp. Ther. 320 3 (2007) 1002-1012
17. Pereira M.P., Hurtado O., Cardenas A., Bosca L., Castillo J., Davalos A., Vivancos J., Serena J., Lorenzo P., Lizasoain I., and Moro M.A. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J. Cereb. Blood Flow Metab. 26 2 (2006) 218-229
18. Richmon J.D., Fukuda K., Maida N., Sato M., Bergeron M., Sharp F.R., Panter S.S., and Noble L.J. Induction of heme oxygenase-1 after hyperosmotic opening of the blood-brain barrier. Brain Res. 780 1 (1998) 108-118
19. Shimamura N., Matchett G., Yatsushige H., Calvert J.W., Ohkuma H., and Zhang J. Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Stroke 37 7 (2006) 1902-1909
20. Solaroglu I., Beskonakli E., Kaptanoglu E., Okutan O., Ak F., and Taskin Y. Transcortical-transventricular approach in colloid cysts of the third ventricle: surgical experience with 26 cases. Neurosurg. Rev. 27 (2004) 89-92
21. Stamatovic S.M., Dimitrijevic O.B., Keep R.F., and Andjelkovic A.V. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir., Suppl. 96 (2006) 444-450
22. Tommasino C. Postoperative cerebral edema. Physiopathology of the edema and medical therapy. Minerva Anestesiol. 58 (1992) 35-42
23. Tureyen K., Kapadia R., Bowen K.K., Satriotomo I., Liang J., Feinstein D.L., and Vemuganti R. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem. 101 1 (2007) 41-56
24. Wang Q., Tang X.N., and Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 184 1-2 (2007) 53-68
25. Williams A.J., Wei H.H., Daves J.R., and Tortella F.C. Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat. J. Neuroinflammation. 4 17 (2007)
26. Xi G., Keep R.F., and Hoff J.T. Pathophysiology of brain edema formation. Neurosurg. Clin. N. Am. 13 3 (2002) 371-383 Jul
27. Yamaguchi M., Jadhav V., Obenaus A., Colohan A., and Zhang J.H. Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically-induced brain injury. Neurosurgery 61 5 (2007) 1067-1075
28. Zhang X., Li H., Hu S., Zhang L., Liu C., Zhu C., Liu R., and Li C. Brain edema after intracerebral hemorrhage in rats: the role of inflammation. Neurol. India 54 4 (2006) 402-407
29. Zhao X., Sun G., Zhang J., Strong R., Song W., Gonzales N., Grotta J.C., and Aronowski J. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann. Neurol. 61 4 (2007) 352-362